Fine Organic Industries Limited has scheduled a Board of Directors meeting for February 12, 2026, to review and approve its unaudited financial results for the third quarter of fiscal year 2026.

Board Meeting Details

The company announced on February 3, 2026, that the Board meeting will consider and approve both standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. This announcement was made pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Trading Window Closure

In accordance with the company's Internal Code of Conduct for Prevention of Insider Trading and SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in equity shares remains closed. The closure period extends from January 1, 2026, to February 14, 2026, both days inclusive.

This trading window closure was previously communicated to the exchanges through a letter dated December 26, 2025, and continues to remain in effect during the financial results consideration period.

Stock Exchange Communication

The formal intimation was sent to both major Indian stock exchanges where the company's shares are listed:

Regulatory Compliance

The announcement demonstrates the company's adherence to regulatory requirements under SEBI guidelines. Company Secretary and Compliance Officer Pooja Lohor, with membership number A28397, signed the official communication digitally on February 3, 2026, at 11:33:11 +05'30'.

The company has requested both exchanges to disseminate this information on their respective websites to ensure proper disclosure to all stakeholders and market participants.

Fine Organic Industries Limited disclosed on January 7, 2026, that it received warning letters from both the National Stock Exchange of India Limited (NSE) and BSE Limited regarding non-compliance with Risk Management Committee meeting requirements. The warnings, dated January 6, 2026, were issued under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Regulatory Non-Compliance Details

The warning letters specifically addressed the company's failure to comply with Regulation 21(3A) of SEBI Listing Regulations, which mandates that the Risk Management Committee must meet at least twice in a financial year. During the financial year 2024-25, Fine Organic Industries' Risk Management Committee convened only once, falling short of the regulatory requirement.

Circumstances Leading to Non-Compliance

According to the company's disclosure, two Risk Management Committee meetings were originally planned for FY 2024-25. However, the second meeting, initially scheduled before March 31, 2025, was rescheduled to April 4, 2025, due to several factors:

• Business exigencies
• Directors' overseas travel commitments
• Time zone differences affecting meeting coordination

Despite the rescheduling, the company maintained that the gap between the two meetings did not exceed the statutory limit of 210 days. Nevertheless, this resulted in only one meeting being held during the financial year ended March 31, 2025.

Exchange Communications and Warnings

Both stock exchanges issued stern warnings to the company regarding the non-compliance. The NSE warning letter, signed by Rakhi Makhloga, Manager – Listing Compliance, emphasized that the non-compliance was viewed seriously and advised the company to exercise due caution to avoid recurrence of such lapses.

Similarly, the BSE warning letter, issued by Deputy Vice President Shilpa Saboo and Deputy Manager Sagar Darra, stated that any future deviation would be viewed with utmost seriousness and may attract appropriate action as deemed necessary.

Company's Response and Corrective Measures

Fine Organic Industries has acknowledged the regulatory breach and outlined its commitment to compliance going forward. The company's response includes:

• Ensuring strict adherence to SEBI Listing Regulations in the future
• Exercising due caution to prevent recurrence of such events
• Implementing corrective measures as advised by the exchanges

The company confirmed that no penalty, restriction, or sanction was imposed pursuant to the warning letters, and there would be no financial implications arising from this communication.

Regulatory Requirements and Disclosure

As mandated by the stock exchanges, Fine Organic Industries was required to disseminate copies of the warning letters and place them before the Board of Directors along with details of corrective measures taken to avoid such lapses. The disclosure was made in compliance with Regulation 30 of SEBI Listing Regulations and relevant SEBI circulars dated November 11, 2024, and February 25, 2025.

The company's proactive disclosure and commitment to enhanced compliance measures demonstrate its intent to maintain regulatory adherence and prevent similar occurrences in future reporting periods.